BIM
ENZN

Bogle Investment Management’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Bogle Investment Management’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-102,163
Closed -$48K – 547
2016
Q1 		$48K Sell
102,163
-4,745
-4% -$2.32K ﹤0.01% 372
2015
Q4 		$72K Sell
106,908
-3,294
-3% -$2.61K 0.01% 364
2015
Q3 		$106K Hold
110,202
– – 0.01% 353
2015
Q2 		$132K Hold
110,202
– – 0.01% 337
2015
Q1 		$116K Sell
110,202
-8,468
-7% -$8.76K 0.01% 341
2014
Q4 		$129K Sell
118,670
-9,919
-8% -$10.4K 0.01% 341
2014
Q3 		$138K Hold
128,589
– – 0.01% 336
2014
Q2 		$133K Sell
128,589
-100
-0.1% -$95 0.01% 323
2014
Q1 		$132K Sell
128,689
-400
-0.3% -$413 0.01% 341
2013
Q4 		$149K Hold
129,089
– – 0.01% 292
2013
Q3 		$216K Sell
129,089
-2,300
-2% -$4.26K 0.02% 297
2013
Q2 		$262K Buy
+131,389
New +$385K 0.03% 264

Other funds holding ENZN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $436M AUM 26.61% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Bogle Investment Management's ENZN Position: Q2 2016 in Review

Bogle Investment Management sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 102,163 shares — an estimated $48K sold.

Bogle Investment Management first reported a position in ENZN in Q2 2013 and held it in 12 quarters. The position peaked at $262K in Q2 2013. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

  • Bogle Investment Management reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
  • Bogle Investment Management sold 102,163 ENZON PHARMACEUTICALS INC shares in Q2 2016, an estimated $48K.
  • Bogle Investment Management first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 12 quarters.
  • Bogle Investment Management's ENZON PHARMACEUTICALS INC position peaked at $262K in Q2 2013.
  • 10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on Bogle Investment Management's 13F filing for Q2 2016, filed 12 Aug 2016.